EDETEK Engages Capgemini to Support Its Global Transformation Initiative and Accelerate AI Innovation in Clinical Development


Article content

NEW YORK — EDETEK Inc., a global provider of leading AI-driven clinical development platforms and services, has engaged Capgemini to support its ongoing advancements in digital transformation within the life sciences industry. This engagement combines EDETEK’s deep domain expertise and established platforms and services with Capgemini’s advanced AI and engineering capabilities, to enable EDETEK to deliver innovative solutions aimed at optimizing clinical development, improving operational efficiency, and accelerating the time-to-market for new therapies.

Article content

Article content

A shared vision for the future of clinical R&D

Article content

Article content

Article content

By integrating advanced digital and data capabilities—including generative AI—across all phases of clinical trials, the project will support new efficiencies for pharmaceutical companies, including:

Article content

  • Dramatically reduce time-to-market for new therapies.
  • Enablement of self-learning, insight-driven trials for faster, more proactive decision-making.
  • Streamlined data management and trial workflows, enhancing efficiency and precision.
  • Significant cost reductions and boosted drug pipeline value.

Article content

“Working with Capgemini signifies our continuing efforts to expand our global capabilities towards delivering more effective and faster clinical development,”

Article content

said Dr. Shakthi Kumar, Chief Strategy & Business Officer at EDETEK.

Article content

“By bringing together our AI-driven platforms with Capgemini’s leading capabilities in life science and technology, we will empower life science organizations to conduct smarter, faster, and more predictive clinical trials—ultimately improving patient outcomes at scale.”

Article content

Bringing innovation to clinical development at scale

Article content

The engagement combines EDETEK’s proven technology with Capgemini’s global network and deep domain knowledge to scale AI-powered clinical innovation across the pharmaceutical industry. Together, this will help make intelligent, agile, and data-driven clinical trials accessible to more life sciences organizations worldwide. In addition, Capgemini will leverage its robust engineering capabilities to help scale EDETEK’s platforms globally and enable continued leadership in reliability, innovation, and performance.

Article content

“Our deep expertise in next-gen clinical development methodologies and advanced AI will expand EDETEK’s R&D cloud and eClinical platform, helping its clients to unlock new levels of agility, insight, and efficiency,”

Article content

said Thorsten Rall, Global Industry Head, Life Sciences at Capgemini.

Article content

“Together, we are committed to redefining what’s possible for the industry—delivering measurable value, accelerating innovation, and shaping the future of healthcare through smarter, more predictive clinical trials.”

Article content

About EDETEK, Inc.

Article content

Founded in 2009, EDETEK delivers high-quality AI-powered platforms and clinical services to over one hundred biopharma clients worldwide. With a presence across four continents, EDETEK is redefining the future of clinical development through intelligent technology.

Article content

Article content

For more information about EDETEK, please visit www.edetek.comAbout Capgemini Capgemini is a global business and technology transformation partner, helping organizations to accelerate their dual transition to a digital and sustainable world, while creating tangible impact for enterprises and society. It is a responsible and diverse group of 340,000 team members in more than 50 countries. With its strong over 55-year heritage, Capgemini is trusted by its clients to unlock the value of technology to address the entire breadth of their business needs. It delivers end-to-end services and solutions leveraging strengths from strategy and design to engineering, all fueled by its market leading capabilities in AI, generative AI, cloud and data, combined with its deep industry expertise and partner ecosystem. The Group reported 2024 global revenues of €22.1 billion.

Article content

Get The Future You Want | www.capgemini.com

Article content

Article content

Article content

View source version on businesswire.com:

Article content

https://www.businesswire.com/news/home/20250610184017/en/

Article content

logo

Article content

Article content

Capgemini press contact:

Article content

Article content

Julia Zimmerman

Article content

Article content

Tel.:+1 847-922-7951

Article content

Article content

E-mail: julia.zimmerman@capgemini.com

Article content

EDETEK press contact:

Article content

Article content

Wei Kong

Article content

Article content

Tel.: +1 609-720-0888

Article content

Article content

E-mail: wei.kong@edetek.com

Article content

Article content

More From Author

New Florida commit Kekua Aumua ‘loved everything’ about latest visit

Three time All-Star Allie Quigley officially announces retirement after 14 seasons

Leave a Reply

Your email address will not be published. Required fields are marked *